When was Metabolon founded?

Metabolon was founded in 2000 and raised its 1st funding round 3 years after it was founded.

Where is Metabolon located?

Metabolon is headquartered in Morrisville, United States. It is registered at Morrisville, North Carolina.

How many employees does Metabolon have?

As of May 31, 2026, the latest employee count at Metabolon is 201.

Is Metabolon a funded company?

Metabolon is a funded company, having raised a total of $166M across 20 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Mar 2003.

When was the latest funding round of Metabolon?

Metabolon's latest funding was a $***** Grant (prize money) round on Feb 06, 2025, with participation from 1 investor. Its primary sector is Metabolic Diseases. In United States, the Metabolic Diseases sector has seen $536M in funding in 2026 to date.

Where does Metabolon rank among its competitors?

Metabolon ranks 4th amongst 94 active competitors, of which 31 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Lexicon Pharmaceuticals, which secured $55.7M in Feb, 2026.

Who are the top competitors of Metabolon?

Metabolon's top competitors include Seer, Tango Therapeutics and Maze Therapeutics. Among them, Lexicon Pharmaceuticals secured the most recent funding round in February, 2026.

Metabolon - 2026 Company Profile, Team, Funding & Competitors

Metabolon is a series H company based in Morrisville (United States), founded in 2000. It operates as a Provider of solutions for biomarker discovery, diagnostic tests and personalized medicine. Metabolon has raised $166M in funding from investors like Sevin Rosen, Fletcher Spaght and Fulcrum Financial Group. The company has 94 active competitors, including 31 funded and 16 that have exited. Its top competitors include companies like Seer, Tango Therapeutics and Maze Therapeutics.

Company Details

Provider of solutions for biomarker discovery, diagnostic tests, and personalized medicine. It offers a biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. It also offers Quantose IR, a lab test for prediabetes assessment and treatment, and Meta IMD, a CLIA assay for inborn errors of metabolism. The company is also developing metabolomics-based clinical diagnostic tests that may improve the early detection of obesity-related metabolic diseases.

Website: metabolon.com
Social
Registered Address: Morrisville, North Carolina

Key Metrics

Founded Year

2000

Location

Morrisville, United States

Stage

Series H

Total Funding

$166M in 20 rounds

Latest Funding Round

Grant (prize money), Feb 06, 2025, $*****

Investors

Sevin Rosen & 18 more

Ranked

4^th among 94 active competitors

Employee Count

201 as on May 31, 2026

Investment & Acquisitions

Metabolomic Discoveries & 2 more

Similar Companies

Seer & 121 more

View Metabolon's full profile

Metabolon is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Metabolon, Inc. CIN: 43518046 , United States, Active	Dec 31, 1999	-	122 (As on Dec 31, 2024)	-
Metabolon, Inc. CIN: 20171291338 , United States, Active	Apr 17, 2017	-	-	-

Metabolon has raised a total funding of $166M over 20 rounds. Its first funding round was on Mar 2003. Its latest funding round was a Grant (prize money) round on Feb 06, 2025 for $*****. 1 investor participated in its latest round. Metabolon has 19 institutional investors.

Here is the list of recent funding rounds of Metabolon:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 06, 2025	9551247	Grant (prize money)	6856724	5028235	1636197	6057275
Dec 31, 2024	3817506	Series H	1292953	5752304	5869901	1001133
May 01, 2024	5504211	Grant (prize money)	9746922	9250775	1370919	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Metabolon's funding rounds and investors

Metabolon's Board of Directors

Metabolon's board has 30 active members. John Fletcher, Scott Barry, John Oxaal, David Pierson, Edward L. Erickson, Robert Cascella, Christopher Kersey, S. Todd Lynch, C. Thomas Caskey, Santo J. Costa, R. John Fletcher, C Thomas Caskey, Carol A. Marino, Edward L Erickson, John A Ryals, Jefferson B. Clark, Stephen Furlong, B. Jefferson Clark, Edward L. Erikson, Gerald M. Haines II, Rudy Howard, Rohan F. Hastie, Jefferson B Clark, Guy Fish, R. Scott Barry, John A. Ryals, Rohan Hastie, Todd Schermerhorn, Jan Lundberg and John Kurtzweil are independent board members.

Here is the list of Metabolon's board of directors:

Name	Type	Representing	Status	Duration
John Fletcher	Independent board member	-	Current	9y 10m
lnscsns	Independent board member	-	Current	5y 3m
dnjlgrt	Independent board member	-	Current	2y 2m
ukdqzrf	Independent board member	-	Current	7y 4m
{yjoikj	Independent board member	-	Current	7y 6m
sgbmbsw	Independent board member	-	Current	9y 4m
vrspfoj	Independent board member	-	Current	4y 4m
kwpwlhl	Independent board member	-	Current	3y 7m
{yfjbrv	Independent board member	-	Current	4y 6m
ritpgwc	Independent board member	-	Current	5y 3m
kgqlcwd	Independent board member	-	Current	1y 9m
buhem{u	Independent board member	-	Current	1y 5m
iyksggf	Independent board member	-	Current	2y 7m
wjdrfto	Independent board member	-	Current	9y 7m
wcnggnp	Independent board member	-	Current	9y 6m
tknmdgc	Independent board member	-	Current	4y 4m
nrzakag	Independent board member	-	Current	8y 9m
bwozwvm	Independent board member	-	Current	5y 7m
oqhsyos	Independent board member	-	Current	6y 9m
ztirgqj	Independent board member	-	Current	3y 3m
knrgoch	Independent board member	-	Current	8y 6m
falhgku	Independent board member	-	Current	4y 5m
buarkrw	Independent board member	-	Current	3y 6m
gm{cgrw	Independent board member	-	Current	6y 8m
slvrsth	Independent board member	-	Current	1y 9m
ziniwss	Independent board member	-	Current	5y 4m
dtdrkhq	Independent board member	-	Current	1y 4m
ivjiv{x	Independent board member	-	Current	2y 7m
hepsuln	Independent board member	-	Current	7y 7m
pjlbt{w	Independent board member	-	Current	4y 5m

Metabolon's employee count trend

Metabolon has 201 employees as of May 26. Here is Metabolon's employee count trend over the years:

Uncover Metabolon's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Metabolon include Seer, Tango Therapeutics and Maze Therapeutics. Here is the list of Top 10 competitors of Metabolon, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Seer 2017, San Francisco (United States), Public	Developer of proteomics platform for early detection of cancer and neurological diseases	$128M	aMoon, Fidelity Investments & 15 others	72/100
2nd	Tango Therapeutics 2017, Cambridge (United States), Public	Developer of drugs for the treatment of cancer	$165M	Boxer Capital, Casdin Capital & 8 others	71/100
3rd	Maze Therapeutics 2018, Redwood City (United States), Public	Developer of genetic bio-markers in neurological, metabolic, and renal diseases	$496M	Matrix Capital Management, Deep Track Capital ... & 21 others	66/100
4th	Metabolon 2000, Morrisville (United States), Series H	Provider of solutions for biomarker discovery, diagnostic tests and personalized medicine	$166M	Camden Partners, Perceptive Advisors & 17 others	66/100
5th	Lexicon Pharmaceuticals 1995, The Woodlands (United States), Public	Developer of small molecule drugs for diffrent health diseases	-	New Enterprise Associates, Bay City Capital ... & 3 others	64/100
6th	Wobble Genomics 2020, Edinburgh (United Kingdom), Series A	Provider of a platform for discovery of nucleic acid biomarkers	$12.5M	Mercia, Eos Advisory & 35 others	62/100
7th	Oxford Biodynamics 2007, Oxford (United Kingdom), Public	Developer of personalized diagnostics by identifying biomarkers through epigenetics	$11M	Armistice Capital, Oxford University Innovation ... & 1 others	56/100
8th	Denovo Biopharma 2013, San Diego (United States), Series D	Developer of genomic biomarker discovery platform	$172M	Guangzhou Yuexiu Industrial Investment Fund Management, Goldstone Investment ... & 12 others	55/100
9th	Valirx 2000, London (United Kingdom), Public	Developer of novel technologies and products in oncology therapeutics and diagnostics	-	-	53/100
10th	Proteostasis 2006, Boston (United States), Public	Developer of novel therapeutics for neurological disease	$168M	Cormorant Asset Management, Healthcare Ventures ... & 9 others	52/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Metabolon's competitors? Click here to see the top ones

Metabolon has acquired 3 companies including Metabolomic Discoveries, Lipomics and Lipomics. Metabolon has not made any investments as of now.

Here is the list of its acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Sep 05, 2017	Acquisition	Metabolomic Discoveries	2009	Potsdam (Germany)
Aug 01, 2012	Acquisition	Lipomics	2000	Sacramento (United States)
Sep 17, 2008	Acquisition	Lipomics	2000	Sacramento (United States)